Figure 3.
Composition of the market for TNF α inhibitors in terms of biosimilar products (2015–2018). Biosimilar market shares (%) for infliximab and etanercept are calculated in relation to the total volume of TNFα inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.